BEIJING, September 5, 2014 /PRNewswire/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in China, is scheduled to participate in the upcoming conferences:
- Morgan Stanley Global Healthcare Conference, to be held September 8-10, 2014 at the Grand Hyatt New York. Management is scheduled to meet with institutional investors throughout September 9-10.
- Morgan Stanley Asia Pacific Healthcare Day, to be held September 11, 2014 at the Boston Harbor Hotel. Management is scheduled to meet with institutional investors throughout the day.
- Aegis Healthcare & Technology Conference, to be held September 10-13, 2014 at the Wynn Las Vegas. Management will present at 1:30 p.m. local time on September 12 and meet with institutional investors throughout the day.
For additional information, please contact the respective institutional sales representative at each sponsoring bank.
About China Biologic Products, Inc.
China Biologic is a leading plasma-based biopharmaceutical company in China. The Company’s products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 different dosages of plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also has an equity investment in Xi’an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and inoculation centers, as well as distributors, in China. For additional information, please see the Company’s website, www.chinabiologic.com.
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191